Kamikihito Enhances Cognitive Functions and Reward-Related Behaviors of Aged C57BL/6J Mice in an Automated Behavioral Assay System.
IntelliCage
aging
anxiety
cognitive function
depression
frailty
kamikihito
kampo (traditional Japanese medicine)
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
03
2020
accepted:
25
06
2020
entrez:
9
8
2020
pubmed:
9
8
2020
medline:
9
8
2020
Statut:
epublish
Résumé
The cognitive and psychological domains of frailty in the elderly have drawn increasing attention given the aging of society. However, therapeutics to treat minor deficits in cognition and mental state in the elderly remain an unmet need. Kamikihito (KKT), a traditional Japanese Kampo medicine indicated for neuroses, anxiety, and insomnia, is effective for treating cognitive dysfunction and depressive-like behaviors in animal models, suggesting that it may have therapeutic potential for treating cognitive and/or mental frailty. In this study, we first validated the known anxiolytic effects of KKT in a conventional maze test. We then introduced an automated behavioral assay system, IntelliCage, to evaluate the therapeutic potential of KKT for age-related and diverse central functions by performing sequential behavioral tasks in young and aged mice to assess basal activities, cognitive functions, perseveration, and hedonic-related behaviors. Although young mice treated with KKT did not exhibit changes in diurnal variation, KKT-administered aged mice exhibited an accelerated decline in voluntary activity during the early part of the light period, implying that KKT may promote sleep onset in aged mice. Neither place learning acquisition for gaining rewards nor subsequent behavioral flexibility performance was altered by KKT in the young group, whereas the aged KKT group exhibited significantly enhanced performance in both phases of learning relative to age-matched controls. Conversely, perseverative nose-pokes (NPs) to gain rewards observed during place learning, indicative of compulsivity, were attenuated by KKT in both age groups. Regarding hedonic processing, aged mice exhibited a decreased preference for sweet solutions compared to young mice, which was effectively reversed by KKT treatment. Furthermore, KKT elevated high-effort choices for high-value reward in an effort-based decision-making paradigm in both age groups, implying augmentation of motivational behaviors by KKT. Collectively, KKT exerted various beneficial effects in cognitive and emotional domains, several of which were more evident in aged mice than in young mice, suggesting the potential of KKT for treating cognitive and mental frailty.
Identifiants
pubmed: 32765263
doi: 10.3389/fphar.2020.01037
pmc: PMC7379479
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1037Informations de copyright
Copyright © 2020 Oizumi, Miyazaki, Tabuchi, Endo, Omiya and Mizoguchi.
Références
J Microbiol Biotechnol. 2012 Mar;22(3):422-30
pubmed: 22450800
Aging Dis. 2017 Dec 1;8(6):708-720
pubmed: 29344412
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
Nutr Res. 2012 Sep;32(9):718-26
pubmed: 23084645
Acta Pharmacol Sin. 2008 Sep;29(9):1109-18
pubmed: 18718180
Jpn J Pharmacol. 1990 Dec;54(4):375-82
pubmed: 2086999
Jpn J Pharmacol. 1994 Apr;64(4):303-6
pubmed: 8057532
Neuroscience. 2009 Sep 15;162(4):1192-201
pubmed: 19463906
Folia Morphol (Warsz). 2019 Nov 14;:
pubmed: 31724150
Neuropsychopharmacology. 2006 Apr;31(4):757-67
pubmed: 16192987
Exp Gerontol. 2012 Jan;47(1):77-84
pubmed: 22075532
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
Phytother Res. 2011 Apr;25(4):501-7
pubmed: 20803480
Obstet Gynecol Int. 2018 Apr 2;2018:9475919
pubmed: 29805451
Neuroscience. 1999;92(4):1343-56
pubmed: 10426489
Prostate Int. 2018 Jun;6(2):55-60
pubmed: 29922633
Aging Dis. 2017 Dec 1;8(6):868-886
pubmed: 29344421
PLoS One. 2013 Dec 16;8(12):e81880
pubmed: 24358130
Jpn J Pharmacol. 1997 Dec;75(4):391-7
pubmed: 9469645
Behav Brain Res. 2011 Aug 1;221(1):172-81
pubmed: 21377499
J Neurosci. 2013 Dec 4;33(49):19120-30
pubmed: 24305809
Front Neural Circuits. 2014 Jun 11;8:58
pubmed: 24966814
Biol Pharm Bull. 2016;39(2):289-94
pubmed: 26830488
Int J Neuropsychopharmacol. 2018 Nov 1;21(11):1049-1065
pubmed: 30239762
Neuropsychopharmacology. 2019 Mar;44(4):793-804
pubmed: 30420603
Neuropsychopharmacology. 2011 Jun;36(7):1518-30
pubmed: 21430652
Pharmacol Biochem Behav. 2002 May;72(1-2):483-90
pubmed: 11900823
J Ginseng Res. 2015 Jul;39(3):250-6
pubmed: 26199557
Behav Brain Res. 2005 Feb 28;157(2):211-7
pubmed: 15639172
Biol Pharm Bull. 1994 Aug;17(8):1132-4
pubmed: 7820124
Jpn J Pharmacol. 1994 Sep;66(1):53-8
pubmed: 7861667
Ageing Res Rev. 2018 Jul;44:1-7
pubmed: 29544875
J Pharmacol Exp Ther. 2001 Aug;298(2):581-91
pubmed: 11454919
J Clin Med. 2019 Sep 27;8(10):
pubmed: 31569684
Behav Pharmacol. 2017 Jun;28(4):303-312
pubmed: 28145981
Neuropsychopharmacology. 2007 Nov;32(11):2321-9
pubmed: 17356573
PLoS One. 2019 Sep 3;14(9):e0222076
pubmed: 31479487
Phytother Res. 2002 Nov;16(7):621-6
pubmed: 12410541
Nat Rev Neurosci. 2007 Mar;8(3):171-81
pubmed: 17299454
Exp Gerontol. 2012 Aug;47(8):552-64
pubmed: 22583982
J Psychopharmacol. 2018 Apr;32(4):441-457
pubmed: 29458297
J Ethnopharmacol. 2014 Sep 11;155(2):1053-60
pubmed: 24960183
Food Chem Toxicol. 2011 Sep;49(9):2229-35
pubmed: 21699953
Neurochem Res. 2017 Dec;42(12):3597-3602
pubmed: 29071534
Phytother Res. 2007 Feb;21(2):126-9
pubmed: 17117451
Front Syst Neurosci. 2019 Sep 24;13:51
pubmed: 31611779
Int J Neurosci. 2011 Dec;121(12):641-8
pubmed: 21770858
PLoS One. 2012;7(12):e50741
pubmed: 23251380
Neuropsychopharmacol Rep. 2019 Jun;39(2):100-118
pubmed: 30816023
Geriatrics (Basel). 2017 Nov 16;2(4):
pubmed: 31011046
J Alzheimers Dis. 2018;62(3):993-1012
pubmed: 29562543
Psychoneuroendocrinology. 2010 Jun;35(5):743-51
pubmed: 19945226
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Phytomedicine. 2008 Aug;15(8):587-94
pubmed: 18289838
Neurobiol Stress. 2016 Aug 24;6:78-93
pubmed: 28229111
Behav Brain Res. 2019 Oct 3;371:111976
pubmed: 31136773
Bioorg Med Chem. 2010 May 1;18(9):3345-51
pubmed: 20363635
Neuron. 2017 Feb 22;93(4):747-765
pubmed: 28231463
Psychopharmacology (Berl). 2015 Jul;232(13):2377-91
pubmed: 25647696
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):265-70
pubmed: 19932727
Psychopharmacology (Berl). 2008 Feb;196(2):269-80
pubmed: 17940750
Pharmacol Toxicol. 2001 May;88(5):282-6
pubmed: 11393591
Learn Mem. 2016 Jun 17;23(7):359-64
pubmed: 27317196